Teladoc Health (NYSE:TDOC) Updates FY24 Earnings Guidance

Teladoc Health (NYSE:TDOC) updated its FY24 earnings guidance on Thursday. The company provided earnings per share guidance of ($1.10)-($0.80) for the period, compared to the consensus earnings per share estimate of ($1.03). The company issued revenue guidance of $2.635-$2.735 billion, compared to the consensus revenue estimate of $2.66 billion. Teladoc Health also updated its Q2 guidance to ($0.45)-($0.35) EPS.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on TDOC. Leerink Partnrs reiterated a market perform rating on shares of Teladoc Health in a research note on Monday, February 26th. SVB Leerink began coverage on Teladoc Health in a research note on Monday, February 26th. They issued a market perform rating and a $17.00 price target for the company. Barclays cut their target price on Teladoc Health from $25.00 to $20.00 and set an overweight rating for the company in a research note on Friday. TD Cowen cut their target price on Teladoc Health from $16.00 to $15.00 and set a hold rating for the company in a research note on Friday. Finally, Stifel Nicolaus cut their target price on Teladoc Health from $21.00 to $16.00 and set a hold rating for the company in a research note on Friday. Eleven investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of Hold and a consensus target price of $19.67.

Teladoc Health Stock Down 2.4 %

Shares of TDOC traded down $0.32 during trading hours on Friday, hitting $13.01. The stock had a trading volume of 7,696,741 shares, compared to its average volume of 4,813,149. The company has a debt-to-equity ratio of 0.66, a quick ratio of 3.47 and a current ratio of 3.54. The firm has a 50 day simple moving average of $15.01 and a 200-day simple moving average of $17.77. Teladoc Health has a 1-year low of $12.65 and a 1-year high of $30.41.

Teladoc Health (NYSE:TDOC) last issued its earnings results on Thursday, April 25th. The health services provider reported ($0.49) EPS for the quarter, missing the consensus estimate of ($0.47) by ($0.02). The firm had revenue of $646.13 million during the quarter, compared to analyst estimates of $637.31 million. Teladoc Health had a negative net margin of 8.90% and a negative return on equity of 10.11%. The business’s quarterly revenue was up 2.7% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.37) earnings per share. Analysts anticipate that Teladoc Health will post -1.07 EPS for the current year.

Insider Activity at Teladoc Health

In related news, insider Laizer Kornwasser sold 7,882 shares of the firm’s stock in a transaction dated Friday, February 2nd. The shares were sold at an average price of $19.18, for a total value of $151,176.76. Following the transaction, the insider now owns 57,223 shares of the company’s stock, valued at approximately $1,097,537.14. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other news, CAO Richard J. Napolitano sold 3,765 shares of the firm’s stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $14.52, for a total transaction of $54,667.80. Following the completion of the sale, the chief accounting officer now owns 18,077 shares in the company, valued at approximately $262,478.04. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Laizer Kornwasser sold 7,882 shares of the firm’s stock in a transaction that occurred on Friday, February 2nd. The stock was sold at an average price of $19.18, for a total transaction of $151,176.76. Following the sale, the insider now owns 57,223 shares of the company’s stock, valued at approximately $1,097,537.14. The disclosure for this sale can be found here. In the last quarter, insiders have sold 135,441 shares of company stock valued at $2,038,251. 1.63% of the stock is owned by corporate insiders.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.